The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata

Molecular Microbiology

Volumn 68, Issue 1, 2008, Pages 186-201

  Torelli, Riccardo ^a   Posteraro, Brunella ^a   Ferrari, Sélène ^b   La Sorda, Marilena ^a   Fadda, Giovanni ^a   Sanglard, Dominique ^b   Sanguinetti, Maurizio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ABC TRANSPORTER; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PYRROLE DERIVATIVE; VORICONAZOLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANDIDA GLABRATA; CGPDR1 GENE; CGSNQ2 GENE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; FUNGAL GENE; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SCSNQ2 GENE; TRANSCRIPTION REGULATION; UPREGULATION;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; AZOLES; BLOTTING, SOUTHERN; CANDIDA GLABRATA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FEMALE; FUNGAL PROTEINS; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

CANDIDA GLABRATA; SACCHAROMYCES CEREVISIAE;

EID: 40549126935     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2008.06143.x     Document Type: Article

References (60)

1. Balzi, E., Wang, M., Leterme, S., Van Dyck, L. Goffeau, A. (1994) PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J Biol Chem 269:2206 2214.
2. Barchiesi, F., Spreghini, E., Fothergill, A., Arzeni, D., Greganti, G., Giannini, D., et al. (2005) Caspofungin in combination with amphotericin B against Candida glabrata. Antimicrobial Agents Chemother 49:2546 2549.
3. Bauer, B.E., Wolfger, H. Kuchler, K. (1999) Inventory and function of yeast ABC proteins: about sex, stress, pleiotropic drug and heavy metal resistance. Biochim Biophys Acta 1461:217 236.
4. Bennett, J.E., Izumikawa, K. Marr, K.A. (2004) Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob Agents Chemother 48:1773 1777.
5. Bissinger, P.H. Kuchler, K. (1994) Molecular cloning and expression of the Saccharomyces cerevisiae STS1 gene product. A yeast ABC transporter conferring mycotoxin resistance. J Biol Chem 269:4180 4186.
6. Cui, Z., Shiraki, T., Hirata, D. Miyakawa, T. (1998) Yeast gene YRR1, which is required for resistance to 4-nitroquinoline N-oxide, mediates transcriptional activation of the multidrug resistance transporter gene SNQ2. Mol Microbiol 29:1307 1315.
7. Decottignies, A., Lambert, L., Catty, P., Degand, H., Epping, E.A., Moye-Rowley, W.S., et al. (1995) Identification and characterization of SNQ2, a new multidrug ATP binding cassette transporter of the yeast plasma membrane. J Biol Chem 270:8150 8157.
8. Delaveau, T., Delahodde, A., Carvajal, E., Subik, J. Jacq, C. (1994) PDR3, a new yeast regulatory gene, is homologous to PDR1 and controls the multidrug resistance phenomenon. Mol Gen Genet 29:501 511.
9. DeRisi, J., van den Hazel, B., Marc, P., Balzi, E., Brown, P., Jacq, C. Goffeau, A. (2000) Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants. FEBS Lett 470:156 160.
10. Devaux, F., Marc, P., Bouchoux, C., Delaveau, T., Hikkel, I., Potier, M.C. Jacq, C. (2001) An artificial transcription activator mimics the genome-wide properties of the yeast Pdrl transcription factor. EMBO Rep 2:493 498.
11. Diekema, D.J., Messer, S.A., Brueggemann, A.B., Coffman, S.L., Doern, G.V., Herwaldt, L.A. Pfaller, M.A. (2002) Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 40:1298 1302.
12. Fidel, P.L. Vazquez, J.A. Sobel, J.D. (1999) Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 12:80 96.
13. Hajjeh, R.A., Sofair, A.N., Harrison, I.H., Lyon, G.M., Arthington-Skaggs, B.A., Mirza, S.A., et al. (2004) Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 42:1519 1527.
14. Izumikawa, K., Kakeya, J., Tsai, J.-F., Grimberg, B. Bennett, J.E. (2003) Function of Candida glabrata ABC transporter gene, PDH1. Yeast 20:249 261.
15. Ju, J.Y., Polhamus, C., Marr, K.A., Holland, S.M. Bennett, J.E. (2002) Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice. Antimicrob Agents Chemother 46:1240 1245.
16. Katzmann, D.J., Burnett, P.E., Golin, J., Mahé, Y. Moye-Rowley, W.S. (1994) Transcriptional control of the yeast PDR5 gene by the PDR3 gene product. Mol Cell Biol 29:4653 4661.
17. Katzmann, D.J., Hallstrom, T.C., Mahé, Y. Moye-Rowley, W.S. (1996) Multiple Pdr1p/Pdr3p binding sites are essential for normal expression of the ATP binding cassette transporter protein-encoding gene. Pdr5 J Biol Chem 29:23049 23054.
18. Kaur, R., Domergue, R., Zupancic, M.L. Cormack, B.P. (2005) A yeast by any other name: Candida glabrata and its interaction with the host. Curr Opin Microbiol 8:378 384.
19. Kitada, K., Yamaguchi, E. Arisawa, M. (1996) Isolation of a Candida glabrata centromere and its use in construction of plasmid vectors. Gene 175:105 108.
20. Klingspor, L., Torngvist, E., Johansson, A., Petrini, B., Forsum, U. Hedin, G. (2004) A prospective epidemiological survey of candidemia in Sweden. Scand J Infect Dis 36:52 55.
21. MacCallum, D.M., Findon, H., Kenny, C.C., Butler, G., Haynes, K. Odds, F.C. (2006) Different consequences of ACE2 and SWI5 gene disruptions for virulence of pathogenic and nonpathogenic yeasts. Infect Immun 74:5244 5248.
22. MacPherson, S., Larochelle, M. Turcotte, B. (2006) A fungal family of transcriptional regulators: the zinc cluster proteins. Microbiol Mol Biol Rev 70:583 604.
23. Mahé, Y., Parle-McDermott, A., Nourani, A., Delahodde, A., Lamprecht, A. Kuchler, K. (1996) The ATP-binding cassette multidrug transporter Snq2 of Saccharomyces cerevisiae: a novel target for the transcription factors Pdr1 and Pdr3. Mol Microbiol 20:109 117.
24. Malani, A., Hmoud, J., Chiu, L., Carver, P.L., Bielaczyc, A. Kauffman, C.A. (2005) Candida glabrata fungemia: experience in a tertiary care center. Clin Infect Dis 41:975 981.
25. Marichal, P., Vanden Bossche, H., Odds, F.C., Nobels, G., Warnock, D.W., Timmerman, V.C., et al. (1997) Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 41:2229 2237.
26. Miyazaki, H., Miyazaki, Y., Geber, A., Parkinson, T., Hitchcock, C., Falconer, D.J., et al. (1998) Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1. Candida glabrata. Antimicrob Agents Chemother 42:1695 1701.
27. National Committee for Clinical Laboratory Standards. (2002) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A2. Wayne, PA:NCCLS.
28. Panackal, A.A., Gribskov, J.L., Staab, J.F., Kirby, K.A., Rinaldi, M. Marr, K.A. (2006) Clinical significance of azole antifungal drug cross-resistance in Candida glabrata. J Clin Microbiol 44:1740 1743.
29. Pappas, P.G., Rex, J.H., Lee, J., Hamill, R.J., Larsen, R.A., Powderly, W., et al. (2003) A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37:634 643.
30. Perea, S. Patterson, T.F. (2002) Antifungal resistance in pathogenic fungi. Clin Infect Dis 35:1073 1080.
31. Perea, S., Lopez-Ribot, J.L., Kirkpatrick, W.R., McAtee, R.K., Santillan, R.A., Martinez, M., et al. (2001) Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 45:2676 2684.
32. Pfaller, M.A. Diekema, D.J. (2004) Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect 10:11 23.
33. Pfaller, M.A., Messer, S.A., Boyken, L., Tendolkar, S., Hollis, R.J. Diekema, D.J. (2003) Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location. J Clin Microbiol 41:2176 2179.
34. Pfaller, M.A., Messer, S.A., Boyken, L., Tendolkar, S., Hollis, R.J. Diekema, D.J. (2004a) Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS antifungal surveillance program conducted in 2001 and 2002. J Clin Microbiol 42:3142 3146.
35. Pfaller, M.A., Messer, S.A., Boyken, L., Hollis, R.J., Rice, C., Tendolkar, S. Diekema, D.J. (2004b) In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. Diagn Microbiol Infect Dis 48:201 205.
36. Posteraro, B., Sanguinetti, M., Sanglard, D., La Sorda, M., Boccia, S., Romano, L., et al. (2003) Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole. Mol Microbiol 47:357 371.
37. Posteraro, B., Sanguinetti, M., Fiori, B., La Sorda, M., Spanu, T., Sanglard, D. Fadda, G. (2006a) Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes. J Antimicrob Chemother 58:458 461.
38. Posteraro, B., Tumbarello, M., La Sorda, M., Spanu, T., Trecarichi, E.M., De Bernardis, F., et al. (2006b) Azole resistance of Candida glabrata in a case of recurrent fungemia. J Clin Microbiol 44:3046 3047.
39. Prasad, R., Gaur, N.A., Gaur, M. Komath, S.S. (2006) Efflux pumps in drug resistance of Candida. Infect Disord Drug Targets 6:69 83.
40. Redding, S.W., Kirkpatrick, W.R., Coco, B.J., Sadkowski, L., Fothergill, A.W., Rinaldi, M.G., et al. (2002) Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer. J Clin Microbiol 40:1879 1881.
41. Redding, S.W., Kirkpatrick, W.R., Saville, S., Coco, B.J., White, W., Fothergill, A., et al. (2003) Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation. J Clin Microbiol 41:619 622.
42. Reuss, O., Vik, A., Kolter, R. Morschhäuser, J. (2004) The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341:119 127.
43. Safdar, A. Armstrong, D. (2002) Prospective evaluation of Candida species colonization in hospitalized cancer patients: impact on short-term survival in recipients of marrow transplantation and patients with hematological malignancies. Bone Marrow Transplant 30:931 935.
44. Sanglard, D. (2002) Resistance of human fungal pathogens to antifungal drugs. Curr Opin Microbiol 5:379 385.
45. Sanglard, D. Odds, F.C. (2002) Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2:73 85.
46. Sanglard, D., Kuchler, K., Ischer, F., Pagani, J.L., Monod, M. Bille, J. (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39:2378 2386.
47. Sanglard, D., Ischer, F., Monod, M. Bille, J. (1996) Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 40:2300 2305.
48. Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P.A. Bille, J. (1999) The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother 43:2753 2765.
49. Sanglard, D., Ischer, F. Bille, J. (2001) Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob Agents Chemother 45:1174 1183.
50. Sanguinetti, M., Posteraro, B., Fiori, B., Ranno, S., Torelli, R. Fadda, G. (2005) Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chemother 49:668 679.
51. Sanguinetti, M., Posteraro, B., La Sorda, M., Torelli, R., Fiori, B., Santangelo, R., et al. (2006) Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans. Infect Immun 74:1352 1359.
52. Servos, J., Haase, E. Brendel, M. (1993) Gene SNQ2 of Saccharomyces cerevisiae, which confers resistance to 4-nitroquinoline-N-oxide and other chemicals, encodes a 169 kDa protein homologous to ATP-dependent permeases. Mol Gen Genet 236:214 218.
53. St. Georgiev, V. (2000) Membrane transporters and antifungal drug resistance. Curr Drug Targets 1:261 284.
54. Trick, W.E., Fridkin, S.K., Edwards, J.R., Hajjeh, R.A., Gaynes, R.P., the National Nosocomial Infections Surveillance System Hospitals (2002) Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 35:622 630.
55. Tsai, H.-F., Krol, A.A., Sarti, K.E. Bennett, J.E. (2006) Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petites mutants. Antimicrob Agents Chemother 50:1384 1392.
56. Vermitsky, J.-P. Edlind, T.D. (2004) Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Antimicrob Agents Chemother 48:3773 3781.
57. Vermitsky, J.-P., Earhart, K.D., Smith, W.L., Homayouni, R., Edlind, T.D. Rogers, P.D. (2006) Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Mol Microbiol 61:704 722.
58. de Waard, M.A., Andrade, A.C., Hayashi, K., Schoonbeek, H.J., Stergiopoulos, I. Zwiers, L.H. (2006) Impact of fungal drug transporters on fungicide sensitivity, multidrug resistance and virulence. Pest Manag Sci 62:195 207.
59. White, T.C., Holleman, S., Dy, F., Mirels, L.F. Stevens, D.A. (2002) Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 46:1704 1713.
60. Yang, C., Bolotin, E., Jiang, T., Sladek, F.M. Martinez, E. (2007) Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters. Gene 389:52 65.